Ong, Thomas Prates 
; Cardozo, Mônica Testoni; Conti, Aline de; Moreno, Fernando Salvador
Source: Current Cancer Drug Targets. Unidade: FCF
Subjects: DANO AO DNA, DIETA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ONG, Thomas Prates et al. Chemoprevention of hepatocarcinogenesis with dietaty isoprenic derivatives: Cellular and molecular aspects. Current Cancer Drug Targets, v. 12, n. 9, p. 1173-1190, 2012Tradução . . Disponível em: https://doi.org/10.1117/12.925754. Acesso em: 11 set. 2024.APA
Ong, T. P., Cardozo, M. T., Conti, A. de, & Moreno, F. S. (2012). Chemoprevention of hepatocarcinogenesis with dietaty isoprenic derivatives: Cellular and molecular aspects. Current Cancer Drug Targets, 12( 9), 1173-1190. doi:10.1117/12.925754NLM
Ong TP, Cardozo MT, Conti A de, Moreno FS. Chemoprevention of hepatocarcinogenesis with dietaty isoprenic derivatives: Cellular and molecular aspects [Internet]. Current Cancer Drug Targets. 2012 ; 12( 9): 1173-1190.[citado 2024 set. 11 ] Available from: https://doi.org/10.1117/12.925754Vancouver
Ong TP, Cardozo MT, Conti A de, Moreno FS. Chemoprevention of hepatocarcinogenesis with dietaty isoprenic derivatives: Cellular and molecular aspects [Internet]. Current Cancer Drug Targets. 2012 ; 12( 9): 1173-1190.[citado 2024 set. 11 ] Available from: https://doi.org/10.1117/12.925754
